Logo image of MDCA

Mdc Partners Cl A (MDCA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MDCA -

5.42
-0.19 (-3.39%)
Last: 8/2/2021, 8:18:12 PM
5.42
0 (0%)
After Hours: 8/2/2021, 8:18:12 PM
Fundamental Rating

1

Taking everything into account, MDCA scores 1 out of 10 in our fundamental rating. MDCA was compared to 95 industry peers in the Media industry. MDCA may be in some trouble as it scores bad on both profitability and health. MDCA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MDCA has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -14.41%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -4.02%
PM (TTM) -19.08%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

MDCA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

MDCA has an Altman-Z score of -0.22. This is a bad value and indicates that MDCA is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of -2.13 indicates that MDCA is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity -2.13
Debt/FCF N/A
Altman-Z -0.22
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.76 indicates that MDCA may have some problems paying its short term obligations.
A Quick Ratio of 0.76 indicates that MDCA may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.76

More info and screens

1

3. Growth

3.1 Past

The earnings per share for MDCA have decreased strongly by -1275.00% in the last year.
The Revenue for MDCA has decreased by -16.67% in the past year. This is quite bad
MDCA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.00% yearly.
EPS 1Y (TTM)-1275%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
Revenue 1Y (TTM)-16.67%
Revenue growth 3Y-7.48%
Revenue growth 5Y-2%
Sales Q2Q%-6.15%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to decrease by -0.68% on average over the next years.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.03%
Revenue Next 2Y-0.68%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MDCA Yearly Revenue VS EstimatesMDCA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B
MDCA Yearly EPS VS EstimatesMDCA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 0 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MDCA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDCA Price Earnings VS Forward Price EarningsMDCA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.93
MDCA Per share dataMDCA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MDCA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Mdc Partners Cl A

NASDAQ:MDCA (8/2/2021, 8:18:12 PM)

After market: 5.42 0 (0%)

5.42

-0.19 (-3.39%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners10.71%
Ins Owner Change0%
Market Cap418.34M
Revenue(TTM)1.18B
Net Income(TTM)-224.96M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.35
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 24.93
EPS(TTM)-3.3
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS15.27
BVpS-5.25
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.41%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -4.02%
PM (TTM) -19.08%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity -2.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.76
Altman-Z -0.22
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1275%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.67%
Revenue growth 3Y-7.48%
Revenue growth 5Y-2%
Sales Q2Q%-6.15%
Revenue Next Year-3.03%
Revenue Next 2Y-0.68%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Mdc Partners Cl A / MDCA FAQ

Can you provide the ChartMill fundamental rating for Mdc Partners Cl A?

ChartMill assigns a fundamental rating of 1 / 10 to MDCA.


What is the valuation status of Mdc Partners Cl A (MDCA) stock?

ChartMill assigns a valuation rating of 0 / 10 to Mdc Partners Cl A (MDCA). This can be considered as Overvalued.


How profitable is Mdc Partners Cl A (MDCA) stock?

Mdc Partners Cl A (MDCA) has a profitability rating of 1 / 10.


What is the financial health of Mdc Partners Cl A (MDCA) stock?

The financial health rating of Mdc Partners Cl A (MDCA) is 2 / 10.